2023
DOI: 10.1007/s00289-023-04922-2
|View full text |Cite
|
Sign up to set email alerts
|

Preliminary in vitro hemocompatibility assessment of biopolymeric hydrogels for versatile biomedical applications

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2

Citation Types

0
2
0

Year Published

2024
2024
2025
2025

Publication Types

Select...
5

Relationship

0
5

Authors

Journals

citations
Cited by 7 publications
(2 citation statements)
references
References 52 publications
0
2
0
Order By: Relevance
“…It is, therefore, crucial to ensure that these materials are hemocompatible to prevent undesirable reactions such as clot formation, platelet activation, and immune responses, all of which can hinder the healing process . Hemocompatible hydrogels play a key role in facilitating healing by fostering an environment conducive to cell proliferation and tissue regeneration while avoiding cytotoxic effects or systemic toxicity resulting from hemolysis . The clinical application of various hybrid hydrogels is typically limited by the challenges associated with incorporating nanomaterials into the hydrogels .…”
Section: Resultsmentioning
confidence: 99%
See 1 more Smart Citation
“…It is, therefore, crucial to ensure that these materials are hemocompatible to prevent undesirable reactions such as clot formation, platelet activation, and immune responses, all of which can hinder the healing process . Hemocompatible hydrogels play a key role in facilitating healing by fostering an environment conducive to cell proliferation and tissue regeneration while avoiding cytotoxic effects or systemic toxicity resulting from hemolysis . The clinical application of various hybrid hydrogels is typically limited by the challenges associated with incorporating nanomaterials into the hydrogels .…”
Section: Resultsmentioning
confidence: 99%
“…These nanomaterials are not readily eliminable from the animal body and their administration in larger quantities is hence unfeasible. The hemolysis assay specifically measures the degree to which a hydrogel causes the destruction of RBC, leading to the release of hemoglobin into the plasma . Hemolysis percentages less than 5% are generally acceptable for biomedical applications, while higher percentages may require further investigation and optimization of the hydrogel .…”
Section: Resultsmentioning
confidence: 99%